About Hematology Oncology Life Center
"Bassam Abi-Rached, MD is a hematologist-oncologist at CHRISTUS Trinity Clinic in Alexandria, Louisiana."
Clinical Trials at Hematology Oncology Life Center
During the past decade, Hematology Oncology Life Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Life Center"
#1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hematology Oncology Life Center
According to Clinical.Site data, the most researched conditions in "Hematology Oncology Life Center" are
"Breast Cancer" (3 trials), "Carcinoma, Small Cell" (2 trials), "Breast Neoplasms" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IIIA" (1 trials) and "Carcinoma Non-small Cell Lung Cancer Stage IIIB" (1 trials). Many other conditions were trialed in "Hematology Oncology Life Center" in a lesser frequency.
Clinical Trials Intervention Types at Hematology Oncology Life Center
Most popular intervention types in "Hematology Oncology Life Center" are "Drug" (7 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Topotecan" (2 trials), "Trastuzumab" (2 trials), "Albumin-bound Paclitaxel" (1 trials), "Docetaxel/Carboplatin" (1 trials) and "Docetaxel/Carboplatin/Bevacizumab/Erlotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology Oncology Life Center
The vast majority of trials in "Hematology Oncology Life Center" are
5 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hematology Oncology Life Center
Currently, there are NaN active trials in "Hematology Oncology Life Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Hematology Oncology Life Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hematology Oncology Life Center, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".